BMNDFBIOMIND LABS INC.
Price Chart
Loading chart...
About BIOMIND LABS INC. (BMNDF)
BIOMIND LABS INC. (BMNDF) is a Biotechnology company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the Pink tier.
Biomind Labs is a biotech research and development company aimed at transforming biomedical sciences knowledge into novel pharmaceutical drugs and innovative nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, Biomind Labs is developing novel pharmaceutical formulations of the main psychedelic molecules, N,N-Dimethyltryptamine ("DMT"), 5-MeO-DMT and mescaline for treating a wide range of therapeutic indications. Biomind Labs' focus is to provide patients access to affordable and modern-day treatments and use cases.
Products and services
Biomind Labs is a biotech research and development company aimed at transforming biomedical sciences knowledge into novel pharmaceutical drugs and innovative nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, Biomind Labs is developing novel pharmaceutical formulations of the main psychedelic molecules, N,N-Dimethyltryptamine ("DMT"), 5-MeO-DMT and mescaline for treating a wide range of therapeutic indications. Biomind Labs’ focus is to provide patients access to affordable and modern-day treatments and use cases.
BMNDF key facts
- Ticker symbol
- BMNDF
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Toronto, ON, Canada
- Country of incorporation
- CA
- Employees
- 15
- Estimated market cap
- $54.30M (as of May 9, 2025)
- Shares outstanding
- 77,571,773
- Reporting standard
- International Reporting: CBOE Canada
- Audit status
- Audited
- Fiscal year end
- 12/31
- Latest filing
- Semi-Annual Report (Jun 30, 2023)
BIOMIND LABS INC. leadership
- Alejandro Carlos Antalich Raibar — CEO
- Oscar Alejandro Leon Bentancor — CFO
- Juan Martin Presa Lombardi — CLO
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with B
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for BIOMIND LABS INC. (BMNDF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Chief Executive Officer
Company Officers
Social Media
Business Details
Stock Details
Loading modules...